farnesoid X receptor antagonists (Chinese Academy of Medical Sciences & Peking Union Medical College/NeuMed Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namefarnesoid X receptor antagonists (Chinese Academy of Medical Sciences & Peking Union Medical College/NeuMed Pharmaceuticals)
Drug Alias NameFXR receptor antagonists (Chinese Academy of Medical Sciences & Peking Union Medical College/NeuMed Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBile acid receptor FXR antagonists
TargetsBile acid receptor FXR
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong KongMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChinese Academy Of Medical Science & Peking Union Medical College
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeuMed Pharmaceuticals LtdChinese Academy Of Medical Science & Peking Union Medical College
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A